Our findings reconcile the paradoxical role of mitochondria in tumor formation and also imply that interventions blocking hypoxic suppression of NRF1 may contribute to therapeutic strategies in curing cancer by reactivating immunity and sensitizing the tumor cells to apoptotic stimuli. The gene discussed is NRF1; the disease is cancer.